Sandu Pharmaceuticals Ltd. Share Price & Stock Analysis

Sandu Pharmaceuticals Ltd. (BSE: 524703) is a Mumbai, Maharashtra-based company in the Vitamins and Nutritional Supplements industry. With a market capitalisation of ₹37 Cr, it ranks #4,016 by market cap among the 6,197 Indian listed companies on FinBizNet, and #3 of 5 in Vitamins and Nutritional Supplements. At ₹37.50 (as of 16 Nov 2026), the share price is 25.0% below its 52-week high of ₹50.00 and 25.0% above its 52-week low of ₹30.00. The share price is down 12.8% over one year and up 3.4% over three months.

Key Metrics

Current Price₹37.50
Market Cap₹37 Cr
BSE Code524703
SectorConsumer Staples > Household and Personal Products > Personal Care Products
Sub-IndustryPersonal Care Products > Vitamins and Nutritional Supplements
P/E Ratio20.7
Return on Equity4.13%
Return on Assets2.60%
52-Week Range₹30.00 – ₹50.00
1-Year Price Change-12.8%
3-Month Price Change+3.4%
Beta (1Y)0.47
Dividend Yield2.64%
HeadquartersMumbai, Maharashtra
Websitesandu.in

Latest Quarterly Results — Q1 FY27

Revenue₹16 Cr
Net Profit₹0 Cr
Net Margin1.4%
EPS (Basic)₹0.37
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Sandu Pharmaceuticals Ltd. Quarterly Revenue and Profit Trend

Sandu Pharmaceuticals Ltd. reported revenue of ₹16 Cr in Q1 FY27, down 1.9% from ₹17 Cr in Q1 FY26 and down 2.7% from ₹17 Cr in Q4 FY26. It posted a net profit of ₹0 Cr for the quarter, against a net profit of ₹0 Cr in Q1 FY26 (up 4.5%). Across the 8 quarters from Q2 FY25 to Q1 FY27, quarterly revenue ranged from ₹14 Cr (Q4 FY25) to ₹19 Cr (Q3 FY26). The company was profitable in each of these 8 quarters.

QuarterRevenueNet ProfitNet Margin
Q1 FY27₹16 Cr₹0 Cr1.4%
Q4 FY26₹17 Cr₹0 Cr0.2%
Q3 FY26₹19 Cr₹1 Cr5.2%
Q2 FY26₹18 Cr₹1 Cr3.0%
Q1 FY26₹17 Cr₹0 Cr1.3%
Q4 FY25₹14 Cr₹0 Cr2.3%
Q3 FY25₹18 Cr₹1 Cr3.0%
Q2 FY25₹18 Cr₹1 Cr2.8%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 74.22% of Sandu Pharmaceuticals Ltd.'s shares as of Mar 2026, unchanged from Mar 2025. Delivery averaged 83.7% of traded volume across 14 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Sandu Pharmaceuticals Ltd.

Sandu Pharmaceuticals Limited manufactures and sells ayurvedic medicines under the SANDU brand in India and internationally. It offers sandu mahasudarshan kadha no 1, sandu abhayarishta, sandu pathyadi kadha, sandu makarprash, sandu gulkand pravalyukta, sandu acivin herbal antacid, sandu ashwagandharishta, sandu amritarishta, sandu hemocleen excellent blood purifier, and sandu vanari granules. The company also provides mahasudarshan kadha, amritarishta, tab. samshamani vati, pathajeevani, vasa cough syrup, whoopin syrup, somajeevani, drakshasava, stressan, ashwagandharishtam, sandu sitopalasava, makarprash, chyavanprash, and ayush kwath. Sandu Pharmaceuticals Limited was founded in 1899 and is based in Mumbai, India.

Products and Services

1. Ayurvedic Property Medicines-This segment engages in the manufacture and marketing of ayurvedic medicines.

Business Segments

1. Ayurvedic Property Medicines-100%

Sandu Pharmaceuticals Ltd. vs Peers — Vitamins and Nutritional Supplements

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Hexagon Nutrition Limited₹737 Cr19.416.26%₹110 Cr—
Aayush Food And Herbs Ltd₹144 Cr36.438.75%—-67.8%
Sandu Pharmaceuticals Ltd.₹37 Cr20.74.13%₹16 Cr-12.8%
Deccan Health Care Ltd₹28 Cr11.92.11%₹22 Cr-30.1%
Walpar Nutritions Limited₹23 Cr9.213.93%—-47.4%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Sandu Pharmaceuticals Ltd.?

Sandu Pharmaceuticals Ltd. is trading at ₹37.50, with a market capitalisation of ₹37 Cr.

Which sector does Sandu Pharmaceuticals Ltd. belong to?

Sandu Pharmaceuticals Ltd. operates in the Consumer Staples > Household and Personal Products > Personal Care Products space (Personal Care Products > Vitamins and Nutritional Supplements).

What are the key financial ratios of Sandu Pharmaceuticals Ltd.?

Sandu Pharmaceuticals Ltd. has a P/E of 20.7 and a return on equity of 4.13%.

What is the stock symbol of Sandu Pharmaceuticals Ltd.?

Sandu Pharmaceuticals Ltd. is listed on the BSE under the scrip code 524703.

How has Sandu Pharmaceuticals Ltd.'s share price moved over the past year?

Sandu Pharmaceuticals Ltd.'s share price is down 12.8% over one year and up 3.4% over three months. Its 52-week range is ₹30.00 to ₹50.00.

What were Sandu Pharmaceuticals Ltd.'s latest quarterly results?

In Q1 FY27, Sandu Pharmaceuticals Ltd. reported revenue of ₹16 Cr and net profit of ₹0 Cr, with basic EPS of ₹0.37 (standalone, parsed from the company's exchange filing).

How have Sandu Pharmaceuticals Ltd.'s revenue and profit changed over the past year?

Sandu Pharmaceuticals Ltd. reported revenue of ₹16 Cr in Q1 FY27, down 1.9% from ₹17 Cr in Q1 FY26 and down 2.7% from ₹17 Cr in Q4 FY26.

What is the promoter holding in Sandu Pharmaceuticals Ltd.?

Promoters held 74.22% of Sandu Pharmaceuticals Ltd.'s shares as of Mar 2026, unchanged from Mar 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.